ArticleBioMed research international2026
Correlation Analysis of Lower Limb Contrast-Enhanced Ultrasound Findings With Serum VEGF and CXCL-12 Levels in a Rabbit Model of Diabetic Foot.
Article in BioMed research international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Correlation Analysis of Lower Limb Contrast-Enhanced Ultrasound Findings With Serum VEGF and CXCL-12 Levels in a Rabbit Model of Diabetic Foot.BioMed research international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
objectiveWe are aimed at analyzing the correlation between contrast-enhanced ultrasound (CEUS) quantitative perfusion parameters and serum levels of vascular endothelial growth factor (VEGF) and C-X-C motif chemokine ligand 12 (CXCL-12) in a rabbit model of diabetic foot, and exploring the value of CEUS in evaluating microcirculatory lesions of diabetic foot.
methodsTen New Zealand white rabbits were intravenously injected with alloxan to induce diabetes (fasting blood glucose > 16 mmol/L, accompanied by symptoms of polydipsia, polyphagia, and polyuria). Diabetic foot ulcer (DFU) was then induced by magnetic disk compression. Serum VEGF and CXCL-12 levels were measured by enzyme-linked immunosorbent assay (ELISA) at three stages (normal stage, diabetes mellitus [DM] stage, and DFU stage). CEUS was performed on the gastrocnemius muscle to quantify three perfusion-related parameters derived from time-intensity curves: time to peak (TTP), peak intensity (PI), and area under the curve (AUC).
resultsSerum VEGF and CXCL-12 levels in diabetic rabbits were significantly higher than those in normal rabbits (p < 0.01); in DFU rabbits, these levels remained elevated but were slightly lower than those in diabetic rabbits (p > 0.1). CEUS-derived perfusion parameters (TTP, PI, and AUC) showed an increasing trend across disease stages, with the highest values observed in the DFU group. All three parameters were significantly positively correlated with serum VEGF and CXCL-12 levels (r = 0.509-0.649, p < 0.01).
conclusionSerum VEGF and CXCL-12 levels increase in diabetes but slightly decrease when DFU develops, indicating microcirculatory decompensation. CEUS-derived perfusion parameters, especially TTP, can sensitively reflect microcirculatory impairment and are positively correlated with angiogenic factor levels. This study suggests that CEUS provides a novel noninvasive tool for evaluating microcirculatory lesions in diabetic foot, with potential clinical translational value.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.